Wide Dissemination of GES-Type Carbapenemases in Acinetobacter baumannii Isolates in Kuwait

Antimicrobial Agents and Chemotherapy - Tập 57 Số 1 - Trang 183-188 - 2013
Rémy A. Bonnin1, Vincent O. Rotimi2, Mona Al Hubail2, Elise Gasiorowski1, Noura Al Sweih2, Patrice Nordmann1, Laurent Poirel1
1Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris-Sud, Le Kremlin-Bicêtre, France
2bDepartment of Microbiology, Faculty of Medicine, Kuwait University, Safat, Kuwait

Tóm tắt

ABSTRACT

Acinetobacter baumannii is an opportunistic pathogen that is an important source of nosocomial infections. Production of extended-spectrum β-lactamases (ESBLs) of the GES type in A. baumannii has been increasingly reported, and some of these GES-type enzymes possess some carbapenemase activity. Our aim was to analyze the resistance determinants and the clonal relationships of carbapenem-nonsusceptible A. baumannii clinical isolates recovered from hospitals in Kuwait. A total of 63 isolates were analyzed, and all were found to be positive for bla GES -type genes. One isolate harbored the bla GES-14 gene encoding an ESBL with significant carbapenemase activity, whereas the other isolates harbored the bla GES-11 ESBL gene. Thirty-three isolates coharbored the bla OXA-23 and bla GES-11 genes. Analyses of the genetic locations indicated that the bla GES-11/-14 genes were plasmid located. It is noteworthy that the bla OXA-23 and bla GES-11 genes were colocated onto a single plasmid. Nine different pulsotypes were observed among the 63 isolates. This study showed the emergence of GES-type ESBLs in A. baumannii in Kuwait, further suggesting that the Middle East region might be a reservoir for carbapenemase-producing A. baumannii .

Từ khóa


Tài liệu tham khảo

10.1128/CMR.00058-07

10.1002/iub.532

10.3201/eid1601.090852

10.1016/j.meegid.2012.02.008

10.1128/AAC.00871-10

10.1128/AAC.00773-10

10.1128/AAC.00072-09

10.1128/AAC.44.3.622-632.2000

10.1099/00207713-47-3-837

Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing (M100-S22). Clinical and Laboratory Standards Institute, Wayne, PA.

10.1128/JCM.06276-11

10.1016/j.diagmicrobio.2011.08.016

10.1128/AAC.00542-10

10.1016/0147-619X(84)90063-5

10.1128/jcm.35.12.3071-3077.1997

10.1111/j.1469-0691.2007.01759.x

10.1371/journal.pone.0010034

10.1128/JCM.01588-06

10.1128/JCM.06462-11

10.1128/AAC.01661-10

10.1128/AAC.00570-08

10.1111/j.1469-0691.2011.03622.x

10.1016/j.diagmicrobio.2010.10.018

10.1093/jac/dkp428

10.1016/j.resmic.2003.10.003

RibeiroA Al-AgamyMH ShiblAM TawfikAF CourvalinP JeannotK. 2012. Molecular epidemiology and mechanisms of carbapenem-resistant Acinetobacter baumannii in a Saudi Arabia hospital (P1256). Clin. Microbiol. Infect. 18:318.